logo
What Is Red Light Therapy and How Does It Work?

What Is Red Light Therapy and How Does It Work?

Health Line2 days ago

Red light therapy (RLT) is a therapeutic technique that uses low-level wavelengths of red light to help treat skin conditions such as wrinkles and psoriasis. Though the treatment seems promising, more research is needed.
Red light therapy (RLT) is a type of phototherapy that may help treat skin conditions, inflammation, muscle pain, and other conditions.
Red light therapy uses light-emitting diode (LED) technology and various wavelengths of light. Some people report that using these lights improves various conditions, but more research is needed to confirm these results.
Read on to learn more about how red light therapy is used and performed.
What is red light therapy?
RLT is commonly referred to as photobiomodulation. It's a type of phototherapy that may help:
treat skin changes like scars, stretch marks, and wrinkles
treat skin conditions such as psoriasis and acne
reduce inflammation or edema
repair muscle tissues
promote healthy aging
Endre Mester discovered it in 1967. He noticed that laser light helped promote hair growth and wound healing in rats.
Scientific literature suggests there are many other names for RLT, such as:
low-level light therapy (LLLT)
soft laser therapy
cold laser therapy
biostimulation
photonic stimulation
low power laser therapy (LPLT)
In the 1990s, scientists used light-emitting diode (LED) technology to grow potatoes in space. The intense red LEDs helped promote photosynthesis, and the scientists reported that their hands healed faster.
Red light was then studied for its potential medicinal application during space travel. Researchers hoped it would help treat muscle atrophy, slow wound healing, and bone density issues caused by weightlessness in space.
Although RLT is gaining traction as a dermatological treatment for certain conditions, more clinical research is needed to fully support its claimed benefits.
How does RLT work?
RLT works by repetitively exposing your skin to low levels of red and near-infrared light for a certain period of time. At low wavelengths, red light doesn't generate heat and penetrates the skin between 1 and 2 millimeters, according to older research from 2013.
This red light exposure may produce a positive biochemical effect in your cells that strengthens the mitochondria, where the cell's energy is created. RLT may do this by increasing the transportation of electrons, oxygen consumption, and levels of ATP (adenosine triphosphate).
By increasing the mitochondria's energy, cells may function more efficiently and rejuvenate and repair themselves.
LEDs are gaining popularity over lasers as the chosen RLT light source because they're nonablative, meaning they help smooth skin without harming the outer layer. LEDs are also nonthermal, meaning they don't produce heat or burn the skin. According to the 2013 research, they may also help:
increase blood flow
reduce inflammation
increase levels of collagen
increase the production of fibroblasts
However, more research is needed to support these claims.
What are the benefits of RLT?
According to a 2018 review of research, many studies suggest promising results of using RLT, but it's still controversial. Additional clinical research is needed to confirm its effectiveness.
That said, studies from the past 20 years suggest that RLT may help:
promote wound healing and tissue repair
reduce some cancer treatment side effects, such as oral mucositis, radiation dermatitis, and lymphedema
improve hair growth in people with androgenic alopecia
treat carpal tunnel syndrome in the short term
reduce myopia progression
reduce psoriasis lesions and burn scars
reduce neuropathic pain
improve neural function and protection to improve cognition and memory for people with Alzheimer's disease
improve skin complexion and build collagen to diminish wrinkles
relieve pain and inflammation in people with pain in the Achilles tendons
RLT may also be used with photosensitizing medications to help treat certain cancers. This is referred to as photodynamic therapy, in which the light only serves as an activating agent for the medication.
Red light therapy and insurance
Many insurance companies don't cover RLT.
If you have health insurance, contact your provider to see whether RLT is covered to help treat your condition.
If you don't have health insurance or your plan does not cover RLT, speak with someone from the doctor's office to see whether they offer payment plans or reduced rates for self-payers.
What are the risks of RLT?
RLT is typically safe and painless. However, experts disagree on whether it is suitable for cancer treatment.
Most studies, such as one from 2022, suggest that RLT may help manage negative cancer treatment side effects.
There have been reports of burns, lesions, and blistering from using RLT units. Some people developed burns:
after using the device for 30 minutes
after falling asleep with the unit in place
due to broken wires or device corrosion
There's also a potential risk of eye damage. Although LEDs are safer on the eyes than traditional lasers, proper eye protection should be worn during RLT.
Where can you get RLT?
Some tanning salons, gyms, and local day spas now offer RLT, which may help reduce signs of aging. You can also find FDA-cleared devices online.
That said, before starting any treatment, it's important to speak with a doctor first. You may need several treatments before noticing any difference in your body. And a doctor may be able to develop a treatment plan that works better for you.
Frequently asked questions
What does red light therapy do?
Red light therapy uses low-level wavelengths of red light to help treat some skin conditions, such as psoriasis. Studies suggest promising results from red light therapy. It may:
promote wound healing and tissue repair
reduce pain and inflammation
reduce psoriasis and burn scars
improve skin complexion
reduce the side effects of some cancer treatments
This said, additional clinical research is still needed to confirm its full effectiveness.
Red light therapy uses low-level wavelengths of red light to help treat some skin conditions, such as psoriasis. Studies suggest promising results from red light therapy. It may:
promote wound healing and tissue repair
reduce pain and inflammation
reduce psoriasis and burn scars
improve skin complexion
reduce the side effects of some cancer treatments
This said, additional clinical research is still needed to confirm its full effectiveness.
Does red light therapy actually work?
Before starting RLT, it's important to speak with a doctor about the best treatment plan for you.
RLT is gaining popularity for its supposed benefits, such as reducing inflammation and signs of aging. For example, some studies, such as a 2018 review of studies and a 2019 research review suggest that RLT may help reduce cancer treatment side effects.
Much of the research has been conducted on animals, so more research with humans is needed.
Before starting RLT, it's important to speak with a doctor about the best treatment plan for you.
RLT is gaining popularity for its supposed benefits, such as reducing inflammation and signs of aging. For example, some studies, such as a 2018 review of studies and a 2019 research review suggest that RLT may help reduce cancer treatment side effects.
Much of the research has been conducted on animals, so more research with humans is needed.
Who should not use red light therapy?
Individuals who have darker skin tones. According to the American Academy of Dermatology, people who have darker skin tones are more sensitive to visible light, such as red light, than people with lighter skin tones, and this sensitivity may lead to side effects like long-lasting hyperpigmentation.
People are taking medication that increases their sensitivity to light may need to avoid red light therapy, and people with medical conditions that make them photosensitive – more sensitive to sunlight.
People are taking medication that increases their sensitivity to light may need to avoid red light therapy, and people with medical conditions that make them photosensitive – more sensitive to sunlight.
Individuals who have darker skin tones. According to the American Academy of Dermatology, people who have darker skin tones are more sensitive to visible light, such as red light, than people with lighter skin tones, and this sensitivity may lead to side effects like long-lasting hyperpigmentation.
People are taking medication that increases their sensitivity to light may need to avoid red light therapy, and people with medical conditions that make them photosensitive – more sensitive to sunlight.
People are taking medication that increases their sensitivity to light may need to avoid red light therapy, and people with medical conditions that make them photosensitive – more sensitive to sunlight.
What are the cons of red light therapy?
Red light therapy can result in burns or blisters from using the device for longer than 30 minutes or due to damage to the device or its parts. Red light therapy is also not typically covered by insurance, and so you may have to pay for it out of pocket.
Researchers have not yet come to a consensus on the safety and efficacy of red light therapy for cancer treatment.
Red light therapy can result in burns or blisters from using the device for longer than 30 minutes or due to damage to the device or its parts. Red light therapy is also not typically covered by insurance, and so you may have to pay for it out of pocket.
Researchers have not yet come to a consensus on the safety and efficacy of red light therapy for cancer treatment.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression
Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression

Associated Press

time8 minutes ago

  • Associated Press

Matter Neuroscience announces collaboration with Stanford Medicine combining Matter protocol with real-time fMRI neurofeedback to support emotion-based interventions in depression

This collaboration sets out to explore whether using the Matter Neuroscience protocol combined with real-time neurofeedback can influence emotional brain networks relevant to depression. PALO ALTO, Calif., June 3, 2025 /PRNewswire/ -- Matter Neuroscience is pleased to announce a collaboration with Stanford Medicine's Psychiatry and Behavioral Sciences Department. The controlled, multi-arm study will enroll at least 210 depressed patients with the objective to significantly reduce clinical endpoints using real-time 7T fMRI neurofeedback in combination with the Matter protocol selectively activating key brain areas hosting distinct positive emotions. The clinical endpoints are paralleled with several molecular, emotional and behavioral biomarkers. If successful, the findings can be integrated into a full-scale clinical trial with the potential to inform future non-pharmaceutical curative therapies for depression. Professor Nolan Williams, M.D. an Associate Professor of Psychiatry and Behavioral Sciences at Stanford University and Director of the Stanford Brain Stimulation Lab will serve as the Principal Investigator on the study. 'This study allows us to investigate how targeted emotion training, guided by real-time fMRI, may influence mood-related brain circuits,' said Dr. Williams. 'What makes this particularly interesting is the opportunity to evaluate both the neural mechanisms involved in emotion regulation and the feasibility of translating this approach into a deliverable treatment in the clinic or home one day.' Matter CEO Axel Bouchon shares, 'After we have seen positive effects in emotional wellbeing of healthy individuals in our studies in the past 4-5 years, it is just one of the most exciting studies I have witnessed in my career. Ultimately, we try to use the latest advancements in MRI technology and the patients' good memories as a personalized medicine to reduce, maybe permanently cure, their depressive symptoms.' About Matter Matter Neuroscience was founded in 2019 by Axel Bouchon and Ben Goldhirsh. Matter's mission is to use neuroscience to help people live longer, healthier, happier lives. Matter Neuroscience runs a consumer technology business ( ) and a medical business addressing healthy individuals and patients, respectively. Matter is led by CEO Axel Bouchon (Moderna, Bayer, ARCH Venture Partners.) Ben Goldhirsh (GOOD Worldwide and the Goldhirsh Foundation) serves as Matter's Chairman and Head of Product. Visit to learn more about Matter. Download the Matter app, named 'App of the Day' on Apple's App Store. Follow Matter on Instagram and Tiktok for education and inspiration for living a happier life. About the Matter Protocol Matter Neuroscience and its academic partners in Maastricht and Copenhagen have conducted several research studies successfully identifying a human map for distinct positive emotions in the brain. Using this map as a directional biomarker, a team led by Professor Rainer Goebel at the Maastricht Brain Imaging Center in the Netherlands developed a protocol that allows for training and intensifying distinct human emotions using real-time fMRI neurofeedback with autobiographical memories. View original content to download multimedia: SOURCE Matter Neuroscience

Hyperinsulinemia Linked to Abnormal Uterine Bleeding
Hyperinsulinemia Linked to Abnormal Uterine Bleeding

Medscape

time34 minutes ago

  • Medscape

Hyperinsulinemia Linked to Abnormal Uterine Bleeding

Hyperinsulinemia appears to have an early association with common causes of abnormal uterine bleeding (AUB), particularly in women with obesity, a preliminary study in Menopause found. Although preliminary, the study data suggested the opportunity for future research on potential relationships between cardiovascular disease risk factors and gynecologic disease. 'Many studies and organizational bodies have examined and asserted a relationship between polycystic ovarian syndrome (PCOS) and elevated insulin levels,' wrote investigators led by Andrea C. Salcedo, DO, MPH, of the Department of Obstetrics and Gynecology at Loma Linda University in Loma Linda, California. They noted that AUB is the most common reason for benign gynecologic consultation in the United States. Andrea C. Salcedo, DO, MPH 'After over 15 years of clinical practice , I started realizing there were several patterns in women who presented with irregular or heavy periods. Many were self-referred or sent by their primary care providers to see me to evaluate for female hormone problems,' Salcedo told Medscape Medical News . 'The majority were not in perimenopause, but they had similar risk factors for cardiovascular disease, such as obesity, hypertension, and migraine headaches.' Salcedo began to wonder whether healthcare providers are recognizing abnormal periods in reproductive age as a cardiovascular risk and using them to educate women on prevention rather than solely treating them medically or surgically. 'I believe that the theory of the uterus as an 'end organ' that receives inflammation in the same way as the heart and kidneys do in cardiovascular disease helps explain to the patient the reasons for heavy or irregular periods.' The study findings came as no surprise to her: 'They confirmed the patterns I was seeing clinically.' Hyperinsulinemia is associated with smooth blood vessel inflammation in the peripheral circulation. 'What is often under-recognized is that the uterus is made of these same blood vessels.' When the uterus is on the receiving end of inflammation, the blood vessels are damaged and do not function appropriately. The result can be uterine fibroids or heavy periods. The gynecologic expression of this inflammation can vary from person to person, she added. The Study This exploratory cross-sectional analysis of the association between hyperinsulinemia and biomarkers of metabolic syndrome in reproductive-aged women with AUB was designed to motivate future hypothesis-driven research. It was conducted from June 2019 to August 2023 at a single institution's outpatient gynecology clinics. A total of 205 premenopausal women aged 18-54 years were enrolled, including 116 with AUB and 89 control individuals with normal menstrual cycles. Approximately 40% in each group were identified as Hispanic. Participants underwent assessment for fasting insulin and additional markers of metabolic syndrome, including body mass index (BMI), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and waist-to-hip ratio. Among the findings: • Hyperinsulinemia, the main effect of interest, was a significant predictor of AUB, affecting 44.0% of the AUB group vs 33.7% of the control group, with an odds ratio of 3.0 (95% CI, 1.372-6.832; P = .0085). • Hypertension, LDL, HDL, smoking, migraines, and polyps or fibroids were all significantly associated with AUB and identified as confounders. Chronic hypertension was identified in 26% of the AUB group vs 12% of the control group. • Interestingly, including BMI in the model diminished the significance of hyperinsulinemia, suggesting overlapping or mediating pathways, the authors said. • Among metabolic markers, LDL levels were similar between groups, while HDL levels were lower in women with AUB (54.0 vs 60.0 mg/dL). • There was a nonsignificant intergroup difference in triglycerides (82.0 vs 73.5 mg/dL) and total cholesterol levels (169.0 vs 172.5 mg/dL). • Migraines were more prevalent in the AUB group (31.0% vs 11.2%), as were polyps or fibroids (45.7% vs 9.6%). Commenting on the study but not involved in it, Maureen Whelihan, MD, a gynecologist at the Center for Sexual Health and Education and Elite GYN Care of the Palm Beaches in Greenacres, Florida, called the study an interesting one, 'suggesting that before we see the effects of PCOS, a diagnosis of hyperinsulinemia can be made and managed and that hyperinsulinemia has a direct effect on microinflammatory injury to the uterus.' Maureen Whelihan, MD In her practice, women with insulin resistance and PCOS have major infertility issues. 'About 85% are obese and have lipid disorders. While this study indicates we can make a diagnosis earlier by evaluating fasting insulin, the question is, 'then what?'' she said. The ultimate remedy is diet and lifestyle modification. 'The minute patients understand they must eliminate starch and sugar to lower insulin levels and move their body a little, we lose them,' she said. 'They want a quick fix and nothing that requires them to make difficult decisions and drastic modifications. This is the hard part! We can teach them the pathophysiology all day, but they have to commit to a permanent change in the way they approach diet and exercise.' While the study findings are exploratory and preliminary, Salcedo said, they suggest that abnormal periods may have predictive value. 'In many cases, elevated fasting insulin levels, above 10 µU/mL, could be an early sign of cardiovascular and diabetes disease risk.' In this study, elevated insulin levels were associated with AUB, particularly among those with obesity. 'Therefore, when a patient sees her healthcare provider for irregular periods, it could be an excellent opportunity to discuss the known association of menstrual problems with [cardiovascular] risk factors.' Larger, longitudinal studies are needed, however, to confirm the causal mechanisms, Salcedo said.

Urbana High graduate, special education advocate looks ahead to Harvard University
Urbana High graduate, special education advocate looks ahead to Harvard University

Yahoo

time37 minutes ago

  • Yahoo

Urbana High graduate, special education advocate looks ahead to Harvard University

After two years of advocating for students living with disabilities in Frederick County Public Schools, a new graduate of Urbana High School is on his way to Harvard University. Jake Kamnikar, 18, joined the Special Education Citizens Advisory Committee (SECAC) during the 2023-24 school year. The committee, while technically a part of the Frederick County Board of Education, is a mandated committee by the Maryland State Department of Education. Committee members include faculty from the special education department at FCPS, community members, parents, other FCPS faculty members and students. Kamnikar was diagnosed with spastic diplegia cerebral palsy at 18 months old, which creates muscle tightness in his lower body as well as hand tremors. He said in an interview that his first year on the committee was 'super interesting,' and that he had never been a part of something like that before. Kamnikar added that while the committee has had student members in the past, 'the year I applied was the first time in a while that they had students back.' 'My cerebral palsy historically has been a hard thing for me to talk about,' he said. 'I wasn't really a big advocate in elementary and middle. Not many kids are. They're little. They're learning about themselves.' Kamnikar's mom, Buffy Kamnikar, said she served on SECAC as a parent when Jake was in kindergarten. 'It was an awesome experience for me as a parent, and they weren't offering a student role at that time,' she said. Buffy Kamnikar said she received an email about the committee accepting student members and showed it to her son. Jake Kamnikar said his mom, dad and family members pushed him to use his voice to advocate for others. 'I know a lot of families are confused or overwhelmed at times with the process of special education, and every kid is different. Their needs vary widely, and a lot of kids aren't able to advocate for themselves,' he said. 'So, if I can make that process easier for students and their families, that's why I wanted to do it.' Jake Kamnikar said his role in the committee was to see firsthand how school board policy affected students living with disabilities. 'My friends in special education programs — how are my general education peers interacting with those students?' he said. 'And what can we do to make improvements and make the school lives, the day-to-day lives, of our students easier?' Jake Kamnikar said elementary and middle school students have a hard time discussing what makes their educational experience difficult. He added that 'the desire is truly there' to help students, but case managers often have a heavy workload and another role within the school system, and sometimes struggle to dedicate enough individualized time working with special education students. 'If you can put a name and a friendly face to whoever you're talking to [about] your disability or your accommodation, that, I think, would go a long way,' he said. 'It would've gone a long way for me.' Jamie Shopland, the chair of SECAC, said Individualized Education Plans are meant to best support students individually, 'and it's different for everyone.' While on SECAC for his junior and senior year, Jake Kamnikar helped create the Student Voices Subcommittee and hosted a Q&A for students living with disabilities and their families. Buffy Kamnikar said the event was nice, and that parents asked questions about special education resources and experiences in the school system. She added that her son is 'probably the most dedicated, hardworking individual I've ever met in my life.' 'He always conducts himself in a way of, how can I be better so the other people around me can be better?' Buffy Kamnikar said. 'I couldn't be more proud.' Shopland said the student perspective on the committee is 'extremely important' to understand how the school board's policies affect students daily. 'If you can understand where people are coming from, then you can connect with them on a different level and in a different way, and be more inclusive and really understand what it means to belong,' she said. Jake Kamnikar said the committee is always looking to increase the number of student voices at the monthly meetings. He added that he had a great time at Urbana High School, and that his favorite topic was economics. Jake Kamnikar said he applied to four Ivy League universities — Yale, Brown, Cornell and Harvard. He said he opened the decision responses from the schools in front of his family, and that after getting rejected from Yale and Cornell and waitlisted at Brown, he opened the Harvard decision and 'couldn't believe what I was reading.' 'It said, 'Jake, we'd love to have you,'' he said. 'I was in shock. I wasn't overly loud or anything — I was just staring at the screen. Mom and Dad were screaming.' Jake Kamnikar said one piece of advice he has for students is to 'trust yourself.' 'The opinions of others are not end-all be-all,' he said. 'There's definitely opportunities for you to work on yourself and grow as a person, and the right people are going to notice you for that and not what they think defines you.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store